Tri(2-butoxyethyl) phosphate

Target genes for Tri(2-butoxyethyl) phosphate is obtained based on ToxCast assay component endpoints.
Chemical nameGene identifierToxCast assay component endpoint name
Tri(2-butoxyethyl) phosphateCCL26BSK_4H_Eotaxin3_down
Tri(2-butoxyethyl) phosphateCOL3A1BSK_hDFCGF_CollagenIII_down
Tri(2-butoxyethyl) phosphateCYP2C19NVS_ADME_hCYP2C19
Tri(2-butoxyethyl) phosphateCYP19A1TOX21_Aromatase_Inhibition
Tri(2-butoxyethyl) phosphateESR1ACEA_ER_80hr
Tri(2-butoxyethyl) phosphateESR1TOX21_ERa_BLA_Antagonist_ratio
Tri(2-butoxyethyl) phosphateESR1TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2
Tri(2-butoxyethyl) phosphateESRRATOX21_PGC_ERR_Antagonist
Tri(2-butoxyethyl) phosphateESRRATOX21_ERR_Antagonist
Tri(2-butoxyethyl) phosphateF3BSK_CASM3C_TissueFactor_down
Tri(2-butoxyethyl) phosphateHLA-DRABSK_3C_HLADR_down
Tri(2-butoxyethyl) phosphateICAM1BSK_KF3CT_ICAM1_up
Tri(2-butoxyethyl) phosphateIL1ABSK_BE3C_IL1a_down
Tri(2-butoxyethyl) phosphateIL6BSK_CASM3C_IL6_down
Tri(2-butoxyethyl) phosphateIRF1ATG_ISRE_CIS_up
Tri(2-butoxyethyl) phosphateARTOX21_AR_BLA_Antagonist_ratio
Tri(2-butoxyethyl) phosphateJUNTOX21_AP1_BLA_Agonist_ratio
Tri(2-butoxyethyl) phosphateFOSTOX21_AP1_BLA_Agonist_ratio
Tri(2-butoxyethyl) phosphateMMP9BSK_KF3CT_MMP9_down
Tri(2-butoxyethyl) phosphateNFE2L2TOX21_ARE_BLA_agonist_ratio
Tri(2-butoxyethyl) phosphateSERPINE1BSK_hDFCGF_PAI1_down
Tri(2-butoxyethyl) phosphatePGRTOX21_PR_BLA_Antagonist_ratio
Tri(2-butoxyethyl) phosphatePLAURBSK_CASM3C_uPAR_up
Tri(2-butoxyethyl) phosphatePPARDTOX21_PPARd_BLA_antagonist_ratio
Tri(2-butoxyethyl) phosphatePPARGATG_PPARg_TRANS_up
Tri(2-butoxyethyl) phosphateRARAATG_DR5_CIS_up
Tri(2-butoxyethyl) phosphateRARBATG_DR5_CIS_up
Tri(2-butoxyethyl) phosphateRARGATG_DR5_CIS_up
Tri(2-butoxyethyl) phosphateCCL2BSK_3C_MCP1_down
Tri(2-butoxyethyl) phosphateSELEBSK_3C_Eselectin_down
Tri(2-butoxyethyl) phosphateTGFB1BSK_KF3CT_TGFb1_down
Tri(2-butoxyethyl) phosphateTSPONVS_MP_hPBR
Tri(2-butoxyethyl) phosphateTIMP1BSK_hDFCGF_TIMP1_down
Tri(2-butoxyethyl) phosphateUSF1ATG_E_Box_CIS_up
Tri(2-butoxyethyl) phosphateVCAM1BSK_CASM3C_VCAM1_down
Tri(2-butoxyethyl) phosphateVDRATG_VDRE_CIS_up
Tri(2-butoxyethyl) phosphateNR1I2NVS_NR_hPXR
Tri(2-butoxyethyl) phosphateNR1I2ATG_PXRE_CIS_up
Tri(2-butoxyethyl) phosphateCD38BSK_SAg_CD38_down
Tri(2-butoxyethyl) phosphateNR1H4TOX21_FXR_BLA_antagonist_ratio
Tri(2-butoxyethyl) phosphateNR1H4OT_FXR_FXRSRC1_0480

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.